Areas of Practice

Ioana represents hospital systems, health care providers, pharmaceutical, biotechnology, and medical device companies, as well as technology and financial firms in high-stakes government investigations and civil litigation. Her litigation and enforcement practice combines depth in antitrust with breadth across commercial, False Claims Act, securities, and restructuring-related matters. Ioana also advises clients on federal and state merger reviews and antitrust risk and compliance.

Experience

Representative Antitrust Matters

  • Representing hotel company in class action litigation involving claims of algorithmic price fixing.
  • Representing music data company in litigation involving monopolization claims.
  • Represented Welsh, Carson, Anderson & Stowe in litigation brought by the Federal Trade Commission and class action plaintiffs alleging antitrust violations in connection with acquisitions by a portfolio company, securing dismissal with prejudice.
  • Represented Nexthink, a digital employee experience platform, in its sale to Vista Equity Partners.
  • Represented TPG in its acquisitions of GE Vernova's Proficy® manufacturing software business and PTC's Kepware industrial connectivity and ThingWorx IoT businesses, expanding TPG's portfolio of industrial technology solutions through its U.S. and European private equity platform.
  • Represented University of Colorado Health (UCHealth) in its partnership with Parkview Health System.
  • Represented Lantheus in its acquisitions of Evergreen Theragnostics and Life Molecular Imaging, including their complementary diagnostic imaging and radioligand therapy assets and manufacturing infrastructure.
  • Represented Convatec in its acquisition of Triad Life Sciences, a biotechnology company focused on the development, manufacture, and commercialization of biologics for the treatment of acute and chronic wounds and other regenerative applications.

Other Experience

  • Represented Sculptor Capital Management in defeating an expedited preliminary injunction action and appeal seeking to block the sale to Rithm Capital Corp.
  • Represented Trinseo Materials Operating S.C.A. and certain of its affiliates in a $1.1 billion financing transaction addressing the company’s 2024 senior secured term loans and $385 million of its 2025 unsecured bonds. Funds managed and advised by Oaktree, Angelo Gordon, and Apollo provided the financing.
  • Represented the independent director of Basic Energy Services, Inc. in the investigation and pursuit of estate causes of action as part of Basic's chapter 11 cases, involving more than $400 million of funded debt.
  • Represented the Special Committee of the Board of Directors of Centric Brands, Inc. in its investigation of potential claims belonging to the estate.
  • Represented leading pharmaceutical and biotechnology companies in False Claims Act government enforcement actions and qui tam litigation.
  • Represented investment management firms and issuer executives in Securities and Exchange Commission investigations into potential violations of securities laws.

Pro Bono

  • Member of the team that secured the exoneration of a Massachusetts man wrongfully convicted and imprisoned for 35 years on the basis of flawed bite mark evidence.
  • Member of the team that represented a diverse coalition of voters in Huot v. City of Lowell, a landmark federal voting rights suit against the city of Lowell, Massachusetts, alleging that its at-large election system illegally diluted the vote of communities of color. The suit resulted in a settlement requiring the city to change its municipal electoral system to ensure fairer and more equitable elections.

Areas of Practice